Discover 901 paid clinical trials in Indianapolis, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Clinical trials in Indianapolis focus on numerous chronic conditions such as lupus, heart disease, and dystrophy. The city’s leading healthcare institutions are actively recruiting participants seeking paid clinical research opportunities as a healthy volunteer, as well as those looking for studies related to a particular health condition to help advance medical knowledge and treatment options in these critical areas.
Filter
2
Filter results
Results: 901
Active & Responsive
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
for
Hereditary Hemorrhagic Telangiectasia (HHT),
Location: Indianapolis IN, Rochester MN, Augusta GA, Boston MA,
Sponsor: Atavistik Bio, Inc
Sex: All
Age: 18+
Code: NCT07601425
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)
for
Sickle Cell Disease
Location: Indianapolis IN, Grand Rapids MI, Flowood MS
Sponsor: Agios Pharmaceuticals, Inc.
Sex: All
Age: 12+
Code: NCT07656415
Phase 3, Recruiting
Active & Responsive
Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
for
Hemophilia A
Location: Indianapolis IN, Cincinnati OH, Chicago IL, Detroit MI,
Sponsor: Wayne State University
Sex: All
Age: 6 - 19
Code: NCT05022459
Recruiting
Active & Responsive
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
for
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Location: Indianapolis IN, Peoria IL, Ann Arbor MI,
Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
Sex: All
Age: 0 - 70+
Code: NCT05500807
Phase 1, Recruiting
Active & Responsive
CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting
for
Cardiac Valve Disease
Location: Indianapolis IN, Cleveland OH, Toronto, Durham NC,
Sponsor: Corcym S.r.l
Sex: All
Age: 0+
Code: NCT05002543
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer